Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|
| Total revenue | 18.48%11.05B | 37.08%9.33B | 6.8B |
| Cost of revenue | 14.21%7.91B | 31.35%6.93B | 5.27B |
| Gross profit | 30.82%3.14B | 56.72%2.4B | 1.53B |
| Operating expense | 6.70%1.62B | 41.98%1.52B | 1.07B |
| Operating profit | 72.58%1.52B | 91.09%879M | 460M |
| Net non-operating interest income (expenses) | -29.23%-84M | -32.65%-65M | -49M |
| Non-operating interest expense | 29.23%84M | 32.65%65M | --49M |
| Net investment income | 137.04%64M | -60.29%27M | 68M |
| Gain(Loss) on financial instruments designated as cash flow hedges | -50.00%17M | 34M | |
| Gain(Loss) on derecognition of available-for-sale financial assets | 34M | 0 | |
| Income from associates and other participating interests | |||
| Special income (charges) | -111.31%-119M | 382.80%1.05B | -372M |
| Less:Restructuring and mergern&acquisition | 89.99%-107M | ---1.07B | ---- |
| Less:Other special charges | 104.59%13M | -1,868.75%-283M | --16M |
| Less:Write off | -29.00%213M | -15.73%300M | --356M |
| Other non-operating income (expenses) | -32.00%34M | -20.63%50M | 63M |
| Income before tax | -26.07%1.46B | 1,077.98%1.98B | 168M |
| Income tax | 53.28%561M | 1,933.33%366M | 18M |
| Net income | -44.14%901M | 975.33%1.61B | 150M |
| Net income continuous operations | -44.08%902M | 975.33%1.61B | --150M |
| Noncontrolling interests | 2M | ||
| Net income attributable to the company | -44.14%901M | 989.86%1.61B | 148M |
| Preferred stock dividends | |||
| Other under preferred stock dividend | 0 | 0 | 0 |
| Net income attributable to common stockholders | -44.14%901M | 989.86%1.61B | 148M |
| Gross dividend payment | |||
| Basic earnings per share | -48.96%104.4301 | 989.86%204.6233 | 18.7751 |
| Diluted earnings per share | -44.14%104.4301 | 989.86%186.9543 | 17.1539 |
| Dividend per share | |||
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |